Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.6216
At close: Jun 2 EDT
$0.6200
-0.00160-0.26%
Pre-Market: 5:37 PM EDT
Comments
Loading...
Lexicon Pharmaceuticals Stock Price, Quotes and Forecasts
LXRXNASDAQ
Lexicon Pharmaceuticals (LXRX) Forecast
NewsEarningsLexicon Pharmaceuticals (LXRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Lexicon Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:LXRX | Benzinga
Explore Lexicon Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LXRX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lexicon Pharmaceuticals (LXRX) stock?
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Who are Lexicon Pharmaceuticals (LXRX) competitors?
Other companies in Lexicon Pharmaceuticals’s space includes: Innate Pharma (NASDAQ:IPHA), Inozyme Pharma (NASDAQ:INZY), Prothena Corp (NASDAQ:PRTA), Tevogen Bio Holdings (NASDAQ:TVGN) and Neurogene (NASDAQ:NGNE).
What is the forecast, or price target, for Lexicon Pharmaceuticals (LXRX) stock?
Lexicon Pharmaceuticals has a consensus price target of $4.50.
What is the current price for Lexicon Pharmaceuticals (LXRX)?
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $0.62 last updated June 2, 2025 at 5:37 PM EDT.
Does Lexicon Pharmaceuticals (LXRX) pay a dividend?
There are no upcoming dividends for Lexicon Pharmaceuticals.
When is Lexicon Pharmaceuticals (NASDAQ:LXRX) reporting earnings?
Lexicon Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 31, 2025.
Is Lexicon Pharmaceuticals (LXRX) going to split?
There is no upcoming split for Lexicon Pharmaceuticals.
What sector and industry does Lexicon Pharmaceuticals (LXRX) operate in?
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
